KNSA Financials
Kiniksa Pharmaceuticals Ltd - Financial statements & key metrics
Stock Price
$79.40
Market Cap
$3.73B
P/E Ratio
91.4
EPS
$0.45
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$423.24M
Gross Profit
-
Operating Income
-
Net Income
$-43.19M
EPS (Diluted)
$-0.60
Balance Sheet Highlights
Total Assets
$580.55M
Total Liabilities
$142.12M
Shareholders Equity
-
Cash & Equivalents
$183.58M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$25.69M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
13.3%
Net Margin
6.0%
ROE
7.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is KNSA revenue?
KNSA's most recent quarterly revenue was $423.24M. Annual revenue can be calculated by summing the four most recent quarters.
Is KNSA profitable?
KNSA reported a loss of $43.19M in the most recent quarter. The net profit margin is 6.0%.
What is KNSA market cap?
KNSA has a market capitalization of $3.73B, making it a mid-cap stock.
Does KNSA have debt?
View KNSA's balance sheet for debt information.
What is KNSA cash flow?
Cash flow data is available in the full financial statements.